INSIGHTS ON QUALITY CONTROL

• Pharmaceutical X-Ray Counts Capsules & Pills

  Learn how advanced X-ray inspection ensures exact pill counts in multi-supplement pouches, automatically identifying missing components and generating time-stamped visual data logs.

• CDMO Audit Coverage: Key Focus Areas And Compliance Objectives

  CDMO audits focus on compliance, quality, performance, and relationships to reduce risk, ensure clear documentation, and align customer expectations with CDMO capabilities.

• Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development

  Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

• Lentiviral Vector Upstream Process

  Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.

• Tackling Residual DNA Testing In Biotherapy Manufacturing

  7/16/2025

  Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.

• Enhance Peptide Innovation With A High-Quality Supply Of Building Blocks

  1/29/2025

  To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.

• Top Questions Before You Buy A Hazardous Pharmacy Compounding Isolator

  6/25/2026

  Move beyond brochure specifications for hazardous compounding. Learn the critical airflow, structural, and pressure requirements needed to ensure long-term facility safety.

• Improved GLP-1 Receptor Agonist Peptide Recovery

  6/30/2025

  Discover how an innovative technology enhances LC-MS analysis of GLP-1 receptor agonists by minimizing peptide loss and improving assay sensitivity and consistency.

• Environmental Monitoring In Advanced Therapeutic Medicinal Products Facilities

  3/5/2026

  Discover how to adapt your environmental monitoring framework to meet the distinct risk-management and regulatory needs of ATMP facility production.